Publication Name	World Journal of Hepatology
Manuscript ID	13452
Country	United States

Received	2014-08-24 16:43
Peer-Review Started	2014-08-26 08:24
To Make the First Decision	2014-12-17 11:21
Return for Revision	2014-12-20 18:52
Revised	2015-02-11 01:42
Second Decision	2015-07-06 08:25
Accepted by Journal Editor-in-Chief	2015-07-06 10:40
Accepted by Executive Editor-in-Chief	2015-07-17 14:14
Articles in Press	2015-07-17 14:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-20 09:11
Publish the Manuscript Online	2015-08-08 13:55

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Hepatitis C: Treatment of difficult to treat patients
Manuscript Source	Invited Manuscript
All Author List	Eric G Hilgenfeldt, Alex Schlachterman and Roberto J Firpi
Funding Agency and Grant Number
Corresponding Author	Roberto J Firpi, MD, MS, AGAF, Director of Hepatology and Liver Transplant, Section of Hepatobiliary Diseases and Transplantation, University of Florida, 1600 SW Archer Rd, MSB Rm M440, Gainesville, FL 32610, United States. roberto.firpi@medicine.ufl.edu
Key Words	Hepatitis C virus; Direct acting antiviral; Human immunodeficiency virus; Cirrhosis; Treatment experienced
Core Tip	The current randomized controlled trials available show favorable sustained virologic responses in patients who are naive to treatment, non-cirrhotic, and not human immunodeficiency virus (HIV)-co-infected. What about patients who do not fit into these categories? In this review, we aim to discuss the currently approved and soon to be approved direct acting antivirals while focusing on their roles in patients that are treatment experienced, cirrhotic, or co-infected with HIV.
Publish Date	2015-08-08 13:55
Citation	Hilgenfeldt EG, Schlachterman A, Firpi RJ. Hepatitis C: Treatment of difficult to treat patients. World J Hepatol 2015; 7(15): 1953-1963
URL	http://www.wjgnet.com/1948-5182/full/v7/i15/1953.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i15.1953

Full Article (PDF)	WJH-7-1953.pdf
Full Article (Word)	WJH-7-1953.doc
Manuscript File	13452-Review.doc
Answering Reviewers	13452-Answering reviewers.pdf
Audio Core Tip	13452-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	13452-Conflict-of-interest statement.pdf
Copyright License Agreement	13452-Copyright assignment.pdf
Peer-review Report	13452-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	13452-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	13452-Scientific misconduct check.pdf
Scientific Editor Work List	13452-Scientific editor work list.pdf